期刊文献+

寡核苷酸阻断ROCK-1蛋白对人卵巢癌细胞恶性行为的影响 被引量:1

Effect of blocking of ROCK-1, an effector of small G protein Rho, on the malignant behavior of ovarian tumor cells in vitro
原文传递
导出
摘要 目的通过反义寡核苷酸(ASODN)对ROCK-1的特异性阻断,探讨ROCK-1蛋白在卵巢癌转移中的作用。方法将ROCK-1反义寡核苷酸(ASODN)以脂质体介导,转染人卵巢癌细胞系SW626和Caov-3细胞,采用逆转录聚合酶链反应(RT-PCR)与Western blot印迹法,检测转染前后ROCK-1蛋白的表达,Boyden小室观察ROCK-1 ASODN对SW626和Caov-3细胞侵袭及迁移能力的影响,采用二苯基溴化四氮唑蓝(MTT)比色法,测定转染前后细胞增殖及黏附能力的变化。结果转染ROCK-1 ASODN后,2株细胞内ROCK-1蛋白的表达明显减少,最大抑制率可达49.0%;细胞的侵袭能力受到明显抑制,10μmol/L组和20μmol/L组SW626细胞的侵袭能力分别为对照组的75.6%±3.8%和54.7%±2.9%,Caov-3细胞为68.8%±4.7%和50.0%±4.5%;转染2种浓度ASODN的SW626和Caov-3细胞的随机运动能力分别为对照组的80.0%±1.3%、63.7%±1.9%、72.0%±1.3%和55.9%±2.5%;定向运动能力分别为对照组的83.9%±1.4%、64.1%±1.3%、72.5%±3.4%和54.5%±1.9%。转染后2株细胞的体外黏附能力和增殖能力,均未显示出明显的变化。结论ROCK-1蛋白的表达与人卵巢癌细胞的体外侵袭和迁移密切相关,阻断ROCK-1的表达,可有效地抑制卵巢癌肿瘤细胞的转移。 Objective To investigate the possible role of ROCK-1 in ovarian cancer invasion and metastasis. Methods ROCK-1 ASODN was transfected into SW626 and Caov-3 cell lines mediated by LipofectamineTM 2000. The expressions of ROCK-I mRNA and protein were detected by RT-PCR and Western-blot assay. Boyden chamber was used to assess the effect of ROCK-1 ASODN on the invasion and migration of the cell lines. The changes in the adhesion and proliferation of the transfected cells were detected by MTI' assay. Results The expressions level of ROCK-1 mRNA and protein in the cell lines were decreased significantly after transfection at doses of 10 μmol/L and 20 μmol/L ROCK-1 ASODN. When compared with the control group, the invasion capability of transfected cells was inhibited to an extent of 75.6% ± 3.8% and 54.7% ± 2.9%, respectively, for SW626 cell line, and 68.8% ± 4.7% and 50.0% ± 4.5% for Caov-3 cell line, respectively. The random migratory activity of these two cell lines was inhibited by 80.0% ± 1.3% , 63.7% ± 1.9%, 72.5% ± 3.4% and 55.9% ± 2.5% , respectively, and the inhibition of chemotaxis activity of the two cell lines was 83.9% ± 1.4% , 64. 1% ± 1.3% , 72.5% ± 3.4% and 54.5% ± 1.9% , respectively. No significant difference was found in the adhesion and proliferation of the cells transfected with ROCK-1 ASODN and control cells. Condusion The expression of ROCK-1 was closely related to the invasion capability and migratory activity of ovarian cancer cells. ROCK-1 may play a crucial role in invasion and metastasis of ovarian cancer.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2007年第10期723-727,共5页 Chinese Journal of Oncology
基金 国家自然科学基金资助项目(30371657) 国家重点基础研究发展规划资助项目(2002CB513100)
关键词 G蛋白Rho ROCK-1蛋白 卵巢肿瘤 G protein Rho ROCK-l Ovarian neoplasms
  • 相关文献

参考文献10

  • 1Kimura K, Ito M, Amano M, et al. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science, 1996, 273:245-248.
  • 2韩志强,张阿丽,吴明富,刘玉兰,陈刚,李辅军,高庆蕾,廖国宁,卢运萍,王世宣,马丁.RhoA、RhoC及其效应分子ROCK-1的表达与卵巢癌细胞系恶性行为相关性的体外研究[J].中华肿瘤杂志,2004,26(7):385-388. 被引量:18
  • 3Takamura M, Sakamoto M, Genda T, et al. Inhibition of intrahepatic metastasis of human hepatocellular carcinoma by Rhoassociated protein kinase inhibitor Y-27632. Hepatology, 2001,33 : 577-581.
  • 4Somlyo AV, Bradshaw D, Ramos S, et al. Rho-kinase inhibitor retards migration and in vivo dissemination of human prostate cancer cells. Biochem Biophys Res Commun, 2000, 269:652-659.
  • 5Maddox AS, Burridge K. RhoA is required for cortical reaction and rigidity during cell rounding. J Cell Biol, 2003, 160:255-265.
  • 6薛妍,毕锋,刘文超,潘阳林,韩者艺,刘娜,刘长江,申慧琴,张学庸.缺氧状况下Rho GTPases的表达和活性变化及其与肿瘤血管生成关系的研究[J].中华肿瘤杂志,2004,26(9):517-520. 被引量:11
  • 7Suyama E, Kawasaki H, Kasaoka T, et al. Identification of genes responsible for cell migration by a library of randomized ribozymes. Cancer Res, 2003, 63 : 119-124.
  • 8Arthur WT, Burridge K. RhoA inactivation by p190RhoGAP regulates cell spreading and migration by promoting membrane protrusion and polarity. Mol Biol Cell, 2001, 12 : 2711-2720.
  • 9Chevrier V, Piel M, Collomb N, et al. The Rho-associated protein kinase p160ROCK is required for centrosome positioning. J Cell Biol, 2002, 157: 807-817.
  • 10Kosako H, Yoshida T, Matsumura F, et al. Rho-kinase/ROCK is involved in cytokinesis through the phosphorylation of myosin light chain and not ezrin/radixin/moesin proteins at the cleavage furrow. Oncogene, 2000, 19: 6059-6064.

二级参考文献23

  • 1Suwa H, Ohshio G, Imamura T, et al. Overexpression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreas.Br J Cancer, 1998,77:147-152.
  • 2Etienne-Manneville S, Hall A. Rho GTPases in cell biology. Nature, 2002,420:629-635.
  • 3Yoshioka K, Matsumura F, Akedo H, et al. Small GTP-binding protein Rho stimulates the actomyosin system, leading to invasion of tumor cells.J Biol Chem, 1998,273:5146-5154.
  • 4Fritz G, Brachetti C, Bahlmann F, et al. Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters. Br J Cancer, 2002,87:635-644.
  • 5Clark EA, Golub TR, Lander ES, et al. Genomic analysis of metastasis reveals an essential role for RhoC. Nature, 2000,406:532-535.
  • 6Amano M, Chihara K, Nakamura N, et al. The COOH terminus of Rho-kinase negatively regulates rho-kinase activity. J Biol Chem, 1999,274:32418-32424.
  • 7Tsuji T, Ishizaki T, Okamoto M, et al. ROCK and mDia1 antagonize in Rho-dependent Rac activation in Swiss 3T3 fibroblasts. J Cell Biol, 2002,157:819-830.
  • 8Genda T, Sakamoto M, Ichida T, et al. Cell motility mediated by rho and Rho-associated protein kinase plays a critical role in intrahepatic metastasis of human hepatocellular carcinoma. Hepatology, 1999,30:1027-1036.
  • 9Fukuda R, Hirota K, Fan F, et al. Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J
  • 10Iyer NV, Kotch LE, Agani F, et al. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev, 1998,12:149-162.

共引文献27

同被引文献25

  • 1Bojesen S E,Pooley K A,Johnatty S E,et al.Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.Nature Genetics,2013,45(4):371-384.
  • 2Burger R A,Brady M F,Bookman M A,et al.Incorporation of bevacizumab in the primary treatment of ovarian cancer.New England Journal of Medicine,2011,365(26):2473-2483.
  • 3Perren T J,Swart A M,Pfisterer J,et al.A phase 3 trial of bevacizumab in ovarian cancer.New England Journal of Medicine,2011,365(26):2484-2496.
  • 4Buys S S,Partridge E,Black A,et al.Effect of screening on ovarian cancer mortality:the prostate,lung,colorectal and ovarian(PLCO)cancer screening randomized controlled trial.Jama,2011,305(22):2295-2303.
  • 5Ledermann J,Harter P,Gourley C,et al.Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer.New England Journal of Medicine,2012,366(15):1382-1392.
  • 6Ha M,Kim V N.Regulation of microRNA biogenesis.Nature Reviews Molecular Cell Biology,2014,15(8):509-524.
  • 7Zhu L,Chen L,Shi C M,et al.MiR-335,an adipogenesisrelated microRNA,is involved in adipose tissue inflammation.Cell Biochemistry and Biophysics,2014,68(2):283-290.
  • 8Cao J,Cai J,Huang D,et al.miR-335 represents an independent prognostic marker in epithelial ovarian cancer.American Journal of Clinical Pathology,2014,141(3):437-442.
  • 9Vigil D,Kim T Y,Plachco A,et al.ROCK1 and ROCK2 are required for non-small cell lung cancer anchorage-independent growth and invasion.Cancer Research,2012,72(20):5338-5347.
  • 10Jeong K J,Park S Y,Cho K H,et al.The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasion.Oncogene,2012,31(39):4279-4289.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部